Low molecular weight cationic lipids for oligonucleotide delivery
US-9725720-B2 · Aug 8, 2017 · US
This page is not indexed by search engines while we improve data quality.
Sirna Therapeutics Inc — Cross-Sectional Technologies
Sirna Therapeutics Inc holds 5 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Sirna Therapeutics Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 5 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2017 |
Representative patents
Notable publications linking Sirna Therapeutics Inc to Cross-Sectional Technologies.
Low molecular weight cationic lipids for oligonucleotide delivery
US-9725720-B2 · Aug 8, 2017 · US
Low molecular weight cationic lipids for oligonucleotide delivery
US-2017015998-A1 · Jan 19, 2017 · US
Low molecular weight cationic lipids for oligonucleotide delivery
US-2017015998-A1 · Jan 19, 2017 · US
Low molecular weight cationic lipids for oligonucleotide delivery
US-9458087-B2 · Oct 4, 2016 · US
Recent filings
Latest patents from Sirna Therapeutics Inc in Cross-Sectional Technologies.
Low molecular weight cationic lipids for oligonucleotide delivery
US-9725720-B2 · Aug 8, 2017 · US
Low molecular weight cationic lipids for oligonucleotide delivery
US-9725720-B2 · Aug 8, 2017 · US
Low molecular weight cationic lipids for oligonucleotide delivery
US-2017015998-A1 · Jan 19, 2017 · US
Low molecular weight cationic lipids for oligonucleotide delivery
US-2017015998-A1 · Jan 19, 2017 · US
Low molecular weight cationic lipids for oligonucleotide delivery
US-9458087-B2 · Oct 4, 2016 · US
Related pages
Navigate to parent entity pages.